300 results on '"Prevots, D. Rebecca"'
Search Results
2. COVID-19 and long-term impact on symptoms and Health-Related Quality of Life in Costa Rica: the RESPIRA cohort study
3. Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States
4. Correction: Nontuberculous mycobacteria testing and culture positivity in the United States
5. Nontuberculous mycobacteria testing and culture positivity in the United States
6. Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation
7. Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review
8. Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort
9. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)
10. Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica
11. Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodology
12. Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis – An analysis of U.S. counties
13. Methods of isolation and identification of nontuberculous mycobacteria from environmental samples: A scoping review
14. Incidence of Nontuberculous Mycobacterial Pulmonary Infection, by Ethnic Group, Hawaii, USA, 2005-2019
15. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria
16. Tenets of a holistic approach to drinking water-associated pathogen research, management, and communication
17. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case–control study in Colorado
18. Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease
19. The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort
20. Estimating vaccine effectiveness against SARS-CoV-2 infection, hospitalization and death from ecologic data in Costa Rica
21. Vanadium in groundwater aquifers increases the risk of MAC pulmonary infection in O’ahu, Hawai’i
22. Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009-2014
23. Mycobacterial Testing Trends, United States, 2009-2015
24. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals : Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
25. Poliomyelitis Prevention in the United States: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP)
26. Poliomyelitis Prevention in the United States: Introduction of A Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
27. Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures
28. Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria: A Review
29. Corrigendum to “Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis – An analysis of U.S. counties” [Tuberculosis 138 (2023) 102296]
30. Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA
31. Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-2012
32. The risk of pulmonary NTM infections and waterquality constituents among persons with cystic fibrosis in the United States, 2010--2019.
33. 43: DIFFICULT-TO-TREAT RESISTANCE IN GRAM-NEGATIVE BACTEREMIA AMONG ICU INPATIENTS AT 162 U.S. HOSPITALS
34. Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot.
35. Trends in Bronchiectasis Among Medicare Beneficiaries in the United States, 2000 to 2007
36. Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital
37. Field Applicability of a Rapid-Format Anti-Ov-16 Antibody Test for the Assessment of Onchocerciasis Control Measures in Regions of Endemicity
38. Trends and Burden of Bronchiectasis-Associated Hospitalizations in the United States, 1993-2006
39. Persistence of Vaccine-Derived Polioviruses among Immunodeficient Persons with Vaccine-Associated Paralytic Poliomyelitis
40. Interruption of Measles Transmission in Brazil, 2000-2001
41. Pulmonary nontuberculous mycobacterial infections: Antibiotic treatment and associated costs
42. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011
43. Tetanus Surveillance — United States, 1995–1997
44. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA
45. Tetanus Surveillance — United States, 1991–1994
46. Assessment of Guillain-Barré Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance
47. Parasite Burden and Severity of Malaria in Tanzanian Children
48. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005
49. Vaccine policy changes and epidemiology of poliomyelitis in the United States
50. Incidence of HIV among injection drug users entering drug treatment programs in four US cities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.